Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine SR for Cognitive Fatigue in MS
NCT01667497Phase 3Completed
- Sponsor
- London Health Sciences Centre
- Start
- Sep 2012
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dalfampridine in multiple sclerosis (MS), sponsored by London Health Sciences Centre. Started Sep 2012; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01667497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667497.